JT
CAMP icon

Jupiter Topco’s CAMP4 Therapeutics CAMP Stock Holding History

Jupiter Topco’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6M Buy
+6,307,636
New +$27.2M 0.01% 574

Other funds holding CAMP

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Jupiter Topco's CAMP Position: Q2 2026 in Review

Jupiter Topco opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 6,307,636 shares worth $27.6M. The stake represents 0.01% of the portfolio and ranks #574 among its holdings.

55 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Jupiter Topco held 6,307,636 shares of CAMP4 Therapeutics worth $27.6M as of Q2 2026.
  • CAMP4 Therapeutics was a new Jupiter Topco position in Q2 2026.
  • CAMP4 Therapeutics made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #574 holding.
  • 55 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.